14th International Cardiovascular Reasearch Meeting

09:15 - 09:20

Opening speech

Jacek Kubica

09:20 - 09:40

Coronary revascularization plus medical therapy or medical therapy alone in elective patients with chronic coronary syndrome (Lecture of the day)

Eliano P. Navarese

09:40 - 09:45

Break

09:45 - 11:00

SESSION 1

09:45 - 10:00

Reduced hospital admissions and increased mortality for acute Heart Failure during COVID-19 pandemic in Poland: a multicentre study (HF-COV-SIRIO 6 study)

Małgorzata Ostrowska

10:00 - 10:15

Predictors of in-hospital clinical outcome in COVID-19 patients

Klaudyna Grzelakowska

10:15 - 10:30

Determinants of anti-SARS-CoV-2 antibodies after vaccination

Magdalena Krintus

10:30 - 10:45

IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the COVID-19 (The IMPACT COVID 19 - SIRIO 5 randomized study)

Jacek Kubica

10:45 - 11:00

DISCUSSION

11:00 - 11:15

Break

11:15 - 12:30

SESSION 2

11:15 - 11:30

Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines

Marco Cattaneo

11:30 - 11:45

Optimal Antithrombotic treatment in COVID-19 Patients

Giuseppe Patti

11:45 - 12:00

Biomarkers of Thrombosis in COVID-19

Diana Gorog

12:00 - 12:15

Aspirin as an Ideal Pharmacologic Therapy for COVID-19

Udaya Tantry

12:15 - 12:30

DISCUSSION

12:30 - 12:45

Break

12:45 - 14:15

SESSION 3

12:45 - 13:00

Inhaled Acetylsalicylic Acid for Immediate Platelet Inhibition

Paul A. Gurbel

13:00 - 13:15

Ethnic difference of thrombogenicity in patients with coronary artery disease

Young-Hoon Jeong

13:15 - 13:30

Optimal duration and combination of antiplatelet therapies following percutaneous coronary intervention

Jolanta Siller-Matula

13:30 - 13:45

Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction

Andrzej Budaj

13:45 - 14:00

Mortality risk prediction in patients with cardiogenic shock (The CardShock study)

Salvatore di Somma

14:00 - 14:15

DISCUSSION

14:15 - 16:15

SESSION 4 - ELECTRA trial investigators meeting

09:00 - 09:20

PCSK9 vaccine – a future therapeutic option or illusory hopes (Lecture of the day)

Maciej Banach

09:20 - 09:30

Break

09:30 - 11:00

SESSION 6

09:30 - 09:45

Acute coronary syndromes in elderly patients

Stefano De Servi

09:45 - 10:00

Cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction (The COOL AMI EU Pivotal Trial)

Marko Noc

10:00 - 10:15

Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention (The TWILIGHT Trial)

Robert Gil

10:15 - 10:30

Resorbable Magnesium Scaffold in ACS patients

Magdalena Łanocha

10:30 - 10:45

Baseline electrocardiographic predictors of Left Ventricular Remodeling in STEMI

Tomasz Fabiszak

10:45 - 11:00

DISCUSSION

11:00 - 11:15

Break

11:15 - 12:30

SESSION 7

11:15 - 11:30

Rivaroxaban in Peripheral Artery Disease (The VOYAGER PAD Trial)

Marc Bonaca

11:30 - 11:45

Venous Thromboembolism in cancer patients

Adam Torbicki

wykład sponsorowany przez firme Pfizer

11:45 - 12:00

Percutaneous mechanical thrombectomy in patients with high-risk pulmonary embolism and contraindications for thrombolytic therapy

Klemen Steblovnik

12:00 - 12:15

Transcriptomic Profiling of Femoral Veins in Deep Vein Thrombosis in a Porcine Model

Leszek Gromadziński

12:15 - 12:30

DISCUSSION

12:30 - 12:45

Break

12:45 - 14:15

SESSION 8

12:45 - 13:00

NCU-AF: on-line qualification for ablation of atrial fibrillation and left atrial appendage occlusion

Piotr Adamski

13:00 - 13:15

Management of patients with coronary artery disease in Lithuania

Jolita Badariene

13:15 - 13:30

Outcomes of managed care in acute myocardial infarction survivors survivors

Piotr Jankowski

13:30 - 13:45

Determinants of elevated lipid parameters in patients without diagnosed car-diovascular disease - results from the polish arm of the EUROASPIRE V sur-vey

Jakub Ratajczak

13:45 - 14:00

PCSK9 inhibitors in acute coronary syndrome

Miłosz Jaguszewski

14:00 - 14:15

DISCUSSION

14:15 - 14:30

Break

14:30 - 15:45

SESSION 9

14:30 - 14:45

Impact of COVID-19 on clinical outcome in acute coronary syndrome patients

Wojciech Wojakowski

14:45 - 15:00

Renal injury in patients admitted due to Covid-19 – single centre experience

Małgorzata Jasiewicz

15:00 - 15:15

Electrotherapy in the COVID-19 era in Poland

Jarosław Kaźmierczak

15:15 - 15:30

ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors

Marek Postuła

15:30 - 15:45

DISCUSSION

15:45 - 17:00

SIRIO MEDICINE network meeting

09:00 - 09:20

On the Shades of Coronary Calcium and Plaque Instability - (Lecture of the day)

Eloisa Arbustini

09:20 - 09:30

Break

09:30 - 11:00

SESSION 11

09:30 - 09:45

Levosimendan improves the acute course of takotsubo syndrome

Miłosz Jaguszewski

09:45 - 10:00

Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Fail-ure and Reduced Ejection Fraction

Jarosław Drożdż

10:00 - 10:15

Multivessel Intervention in Myocardial Infarction with Cardiogenic Shock (CULPRIT-SHOCK Trial Outcomes in the PL-ACS Registry)

Przemysław Trzeciak

10:15 - 10:30

Long-term outcomes following drug-eluting balloons versus thin-strut drug-eluting stents for treatment of in-stent restenosis (DEB-Dragon-Registry)

Piotr Niezgoda

10:30 - 10:45

The impact of the COVID-19 pandemic on the functioning of the emergency medical service

Michał Kasprzak

10:45 - 11:00

DISCUSSION

11:00 - 11:15

Closing remarks

Jacek Kubica

SCIENTIFIC PROGRAMME

We invite you to familiarize yourself with the details of the program.

Contact